Novo Nordisk diabetes drug tops Byetta in trial (Reuters)

[riky]

Novo Nordisk diabetes drug tops Byetta in trial
    (Reuters)

 


Reuters - Novo Nordisk's experimental type 2
diabetes drug, liraglutide, was superior in controlling blood
sugar in a clinical trial to Eli Lilly and Co and Amylin
Pharmaceuticals Inc's Byetta, the Danish company said on
Friday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080606/hl_nm/diabetes_novo_dc